B

Blue Jet Healthcare Ltd
NSE:BLUEJET

Watchlist Manager
Blue Jet Healthcare Ltd
NSE:BLUEJET
Watchlist
Price: 539.55 INR 0.29%
Market Cap: 93.6B INR

Blue Jet Healthcare Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Blue Jet Healthcare Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
B
Blue Jet Healthcare Ltd
NSE:BLUEJET
EPS (Diluted)
₹17
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
EPS (Diluted)
₹69
CAGR 3-Years
-28%
CAGR 5-Years
-6%
CAGR 10-Years
-2%
Cipla Ltd
NSE:CIPLA
EPS (Diluted)
₹67
CAGR 3-Years
28%
CAGR 5-Years
24%
CAGR 10-Years
12%
Divi's Laboratories Ltd
NSE:DIVISLAB
EPS (Diluted)
₹93
CAGR 3-Years
-6%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Lupin Ltd
NSE:LUPIN
EPS (Diluted)
₹94
CAGR 3-Years
299%
CAGR 5-Years
N/A
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
EPS (Diluted)
₹63
CAGR 3-Years
39%
CAGR 5-Years
12%
CAGR 10-Years
4%
No Stocks Found

Blue Jet Healthcare Ltd
Glance View

Market Cap
93.6B INR
Industry
N/A

Blue Jet Healthcare Ltd is a IN-based company operating in industry. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2023-11-01. Blue Jet Healthcare Limited is an India-based specialty pharmaceutical and healthcare ingredients and intermediates company. The Company’s operations are primarily organized in three product categories: contrast media intermediates, high-intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs). Contrast media are agents used in medical imaging to enhance the visibility of body tissues under X-rays, computed tomography (CT), magnetic resonance imaging (MRI) or ultrasound. Its high-intensity sweetener business includes development, manufacturing and marketing of saccharin and its salts. The Company’s contract development and manufacturing organization (CDMO) activity in the pharma intermediate and API business is primarily focused on collaborating with innovator pharmaceutical companies and multi-national generic pharmaceutical companies by providing them with pharma intermediates that serve as building blocks for APIs in chronic therapeutic areas.

BLUEJET Intrinsic Value
HIDDEN
Show

See Also

What is Blue Jet Healthcare Ltd's EPS (Diluted)?
EPS (Diluted)
17.6 INR

Based on the financial report for Mar 31, 2025, Blue Jet Healthcare Ltd's EPS (Diluted) amounts to 17.6 INR.

What is Blue Jet Healthcare Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
19%

Over the last year, the EPS (Diluted) growth was 86%. The average annual EPS (Diluted) growth rates for Blue Jet Healthcare Ltd have been 19% over the past three years .

Back to Top